Zobrazeno 1 - 10
of 13
pro vyhledávání: '"Carole Achard"'
Autor:
Carole Achard, Abera Surendran, Marie-Eve Wedge, Guy Ungerechts, John Bell, Carolina S. Ilkow
Publikováno v:
EBioMedicine, Vol 31, Iss , Pp 17-24 (2018)
Oncolytic virus (OV) therapy is potentially a game-changing cancer treatment that has garnered significant interest due to its versatility and multi-modal approaches towards tumor eradication. In the field of cancer immunotherapy, the immunological p
Externí odkaz:
https://doaj.org/article/e33778759e55432b9d99062d2bf747b2
Autor:
Frédéric Tangy, Carole Achard, Marc Grégoire, Tiphaine Delaunay, Jean-François Fonteneau, Nicolas Boisgerault
Publikováno v:
Methods in Molecular Biology
Methods in Molecular Biology, 2020, 2058, pp.127-132. ⟨10.1007/978-1-4939-9794-7_8⟩
Methods in Molecular Biology, Humana Press/Springer Imprint, 2020, 2058, pp.127-132. ⟨10.1007/978-1-4939-9794-7_8⟩
Methods in Molecular Biology ISBN: 9781493997930
Methods in Molecular Biology, 2020, 2058, pp.127-132. ⟨10.1007/978-1-4939-9794-7_8⟩
Methods in Molecular Biology, Humana Press/Springer Imprint, 2020, 2058, pp.127-132. ⟨10.1007/978-1-4939-9794-7_8⟩
Methods in Molecular Biology ISBN: 9781493997930
International audience; Oncolytic immunotherapy efficacy relies partially on the induction of immunogenic tumor cell death following infection with oncolytic viruses (OV) to induce an antitumor immune response. Here, we describe a method to determine
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::582b2eb88243dd03e6adf69f614c1ad6
https://www.hal.inserm.fr/inserm-02285959
https://www.hal.inserm.fr/inserm-02285959
Autor:
Christophe Blanquart, Stephane Minvielle, Laurent Cellerin, Nicolas Boisgerault, Jaafar Bennouna, Didier Jean, Pierre-Joseph Royer, Marion Grard, Tiphaine Delaunay, Jean-François Fonteneau, Camille Chatelain, Carole Achard, Marc Grégoire, Clément Meiller, Antoine Magnan, Frédéric Tangy, Lisa Quetel, Delphine Fradin, Soizic Dutoit, Tacien Petithomme
Publikováno v:
Journal of Thoracic Oncology
Journal of Thoracic Oncology, Lippincott, Williams & Wilkins, 2020, S1556-0864(20)30019-8, Epub ahead of print. ⟨10.1016/j.jtho.2019.12.128⟩
Journal of Thoracic Oncology, 2020, S1556-0864(20)30019-8, Epub ahead of print. ⟨10.1016/j.jtho.2019.12.128⟩
Journal of Thoracic Oncology, Lippincott, Williams & Wilkins, 2020, S1556-0864(20)30019-8, Epub ahead of print. ⟨10.1016/j.jtho.2019.12.128⟩
Journal of Thoracic Oncology, 2020, S1556-0864(20)30019-8, Epub ahead of print. ⟨10.1016/j.jtho.2019.12.128⟩
Introduction Oncolytic immunotherapy is based on the use of nonpathogenic replicative oncolytic viruses that infect and kill tumor cells exclusively. Recently, we found that the spontaneous oncolytic activity of the Schwarz strain of measles virus (M
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e74ff75083ee017e786aeca0f9e711e7
https://www.hal.inserm.fr/inserm-02447160/document
https://www.hal.inserm.fr/inserm-02447160/document
Autor:
John C. Bell, Carolina S. Ilkow, Guy Ungerechts, Abera Surendran, Carole Achard, Marie Eve Wedge
Publikováno v:
EBioMedicine, Vol 31, Iss, Pp 17-24 (2018)
EBioMedicine
EBioMedicine
Oncolytic virus (OV) therapy is potentially a game-changing cancer treatment that has garnered significant interest due to its versatility and multi-modal approaches towards tumor eradication. In the field of cancer immunotherapy, the immunological p
Autor:
Nadège Goutagny, Isabelle Durand, Colette Dezutter-Dambuyant, Thierry Walzer, Raffaella Ghittoni, Jacqueline Marvel, Carole Achard, Florence Deauvieau, Jean-François Fonteneau, Estelle Verronese, Anne-Claire Doffin, Ivan Perrot, Jenny Valladeau-Guilemond, Vincent Ollion, Henri Vié, Christophe Caux
Publikováno v:
International Journal of Cancer. 136:1085-1094
Dendritic cells (DCs) cross-present antigen (Ag) to initiate T-cell immunity against most infections and tumors. Natural killer (NK) cells are innate cytolytic lymphocytes that have emerged as key modulators of multiple DC functions. Here, we show th
Autor:
Sophie Iochmann, Christelle Parent, Yves Courty, Nathalie Heuzé-Vourc'h, Carole Achard, Brice Korkmaz, Renaud Respaud, Audrey Guillon-Munos, Sylvain Marchand-Adam, Thomas Kryza
Publikováno v:
The FASEB Journal. 28:740-751
KLK12, a kallikrein peptidase, is thought to take part in the control of angiogenesis. Our analysis of the secretome of endothelial cells (ECs) that had been treated with KLK12 showed that KLK12 converts the extracellular matrix- or membrane-bound pr
Autor:
Brigitte Dréno, Amel Benammar Elgaaied, Jean-François Fonteneau, Marc Grégoire, Clarisse Panterne, Carole Achard, Daniel Pouliquen, Nicolas Boisgerault, Frédéric Tangy, Ferdaous Allagui, Chantal Combredet, Nathalie Labarrière
Publikováno v:
Current Gene Therapy
Current Gene Therapy, 2016, ⟨10.2174/156652321766617010211⟩
Current Gene Therapy, Bentham Science Publishers, 2016, ⟨10.2174/156652321766617010211⟩
Current Gene Therapy, 2016, ⟨10.2174/156652321766617010211⟩
Current Gene Therapy, Bentham Science Publishers, 2016, ⟨10.2174/156652321766617010211⟩
International audience; Background: Oncolytic viruses such as live-attenuated, vaccine strains of measles virus (MV) have recently emerged as promising cancer treatments, having shown significant antitumor activity against a large variety of human tu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a6df4e6a8d759b39e7980352e384c5b
https://www.hal.inserm.fr/inserm-01480242
https://www.hal.inserm.fr/inserm-01480242
Autor:
Florence, Deauvieau, Vincent, Ollion, Anne-Claire, Doffin, Carole, Achard, Jean-François, Fonteneau, Estelle, Verronese, Isabelle, Durand, Raffaella, Ghittoni, Jacqueline, Marvel, Colette, Dezutter-Dambuyant, Thierry, Walzer, Henri, Vie, Ivan, Perrot, Nadège, Goutagny, Christophe, Caux, Jenny, Valladeau-Guilemond
Publikováno v:
International Journal of Cancer
International Journal of Cancer, Wiley, 2015, 136 (5), pp.1085-1094. ⟨10.1002/ijc.29087⟩
International Journal of Cancer, 2015, 136 (5), pp.1085-1094. ⟨10.1002/ijc.29087⟩
International Journal of Cancer, Wiley, 2015, 136 (5), pp.1085-1094. ⟨10.1002/ijc.29087⟩
International Journal of Cancer, 2015, 136 (5), pp.1085-1094. ⟨10.1002/ijc.29087⟩
International audience; Dendritic cells (DCs) cross-present antigen (Ag) to initiate T-cell immunity against most infections and tumors. Natural killer (NK) cells are innate cytolytic lymphocytes that have emerged as key modulators of multiple DC fun
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid_dedup__::ce4acf10972f3fc1afaa7001e4c6fc25
https://www.hal.inserm.fr/inserm-02913986/file/ijc.29087.pdf
https://www.hal.inserm.fr/inserm-02913986/file/ijc.29087.pdf
Autor:
Nicolas Boisgerault, Marc Grégoire, Jean-François Fonteneau, Frédéric Tangy, Tiphaine Delaunay, Carole Achard
Publikováno v:
Journal of Clinical and Cellular Immunology
Journal of Clinical and Cellular Immunology, OMICS Publishing Group, 2015, 6 (1), http://omicsonline.org/open-access/induction-of-immunogenic-tumor-cell-death-by-attenuated-oncolytic-measles-virus-2155-9899-1000291.php?aid=38192. ⟨10.4172/2155-9899.1000291⟩
Journal of Clinical and Cellular Immunology, 2015, 6 (1), http://omicsonline.org/open-access/induction-of-immunogenic-tumor-cell-death-by-attenuated-oncolytic-measles-virus-2155-9899-1000291.php?aid=38192. ⟨10.4172/2155-9899.1000291⟩
Journal of Clinical and Cellular Immunology, OMICS Publishing Group, 2015, 6 (1), http://omicsonline.org/open-access/induction-of-immunogenic-tumor-cell-death-by-attenuated-oncolytic-measles-virus-2155-9899-1000291.php?aid=38192. ⟨10.4172/2155-9899.1000291⟩
Journal of Clinical and Cellular Immunology, 2015, 6 (1), http://omicsonline.org/open-access/induction-of-immunogenic-tumor-cell-death-by-attenuated-oncolytic-measles-virus-2155-9899-1000291.php?aid=38192. ⟨10.4172/2155-9899.1000291⟩
International audience; Antitumor virotherapy is a developing approach to treat cancer with oncolytic viruses, namely replicative viruses that exclusively or preferentially infect and kill tumor cells. Attenuated strains of Measles Virus (MV) are now
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b481d66d313f97dfbe3c99d65b653813
https://www.hal.inserm.fr/inserm-01148993/file/induction-of-immunogenic-tumor-cell-death-by-attenuated-oncolytic-measles-virus-2155-9899-1000291.pdf
https://www.hal.inserm.fr/inserm-01148993/file/induction-of-immunogenic-tumor-cell-death-by-attenuated-oncolytic-measles-virus-2155-9899-1000291.pdf
Autor:
Jean-François Fonteneau, Nicolas Boisgerault, Marc Grégoire, Carole Achard, Frédéric Tangy, Laurent Cellerin, Tiphaine Delaunay
Publikováno v:
Oncolytic Virotherapy
Oncolytic Virotherapy, 2015, ⟨10.2147/OV.S66091⟩
Oncolytic Virotherapy, DovePress, 2015, ⟨10.2147/OV.S66091⟩
Oncolytic Virotherapy, 2015, ⟨10.2147/OV.S66091⟩
Oncolytic Virotherapy, DovePress, 2015, ⟨10.2147/OV.S66091⟩
International audience; Cancer virotherapy is an attractive alternative to conventional treatments because it offers a wide range of antitumor effects due to 1) the diversity of the oncolytic viruses that are now available and 2) their multifaceted a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a23c07501bfc8b53c0f0d6334aab367
https://www.hal.inserm.fr/inserm-01285355
https://www.hal.inserm.fr/inserm-01285355